Does N-acetylcysteine increase the excretion of trace metals (calcium, magnesium, iron, zinc and copper) when given orally?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
N-Acetylcysteine (NAC) is known to decrease the exacerbation rate in patients with chronic bronchitis. It has also been shown that NAC has both an oxygen-radical scavenger and a heavy-metal chelating effect in high intravenous doses. In a study lasting 5 weeks, 10 healthy volunteers were treated with NAC 200 mg t. d. s. for two weeks. The concentrations of trace metals (Ca, Mg, Fe, Zn & Cu) in plasma were measured weekly and daily in a morning spot urine during the investigation.
No significant change in plasma concentration or excretion was found during the two weeks of treatment, implying that additional administration of trace metals is unnecessary for patients treated perorally with a therapeutic dose of NAC.
- Sheffner, AL (1963) The reduction in vitro in viscosity of muco- protein solutions by a new mucolytic agent, N-Acetylcysteine. Ann NY Acad Sci 106: pp. 298-310 CrossRef
- Hurst, GA, Shaw, PB, LeMaistre, CA (1967) Laboratory and clini- cal evaluation of the mucolytic properties of acetylcysteine. Am Rev Respir Dis 96: pp. 962-970
- Kory, RC, Hirsch, RS, Giraldo, J (1968) Nebulization of N-Ace- tylcysteine combined with a bronchodilator in patients with chronic bronchitis. Dis Chest 54: pp. 18-23
- Cotgreave, IA, Eklund, A, Larsson, K, Moldéus, PW (1987) No penetration of orally administered N-acetylcysteine into bron- choalveolar lavage fluid. Eur J Respir Dis 70: pp. 73-77
- Jeffery, P (1986) Anti-inflammatory drugs and experimental bronchitis. Eur J Respir Dis 69: pp. 245-257
- Grassi, C, Morandini, GC (1976) A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bron- chitis. Eur J Clin Pharmacol 9: pp. 393-396 CrossRef
- Boman, G, Bficker, U, Larsson, S, Melander, B, Wåhlander, L (1983) Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 64: pp. 405-415
- Moldéus, P, Cotgrave, IA, Berggren, M (1986) Lung protection by a thiol-containing antioxidant: N-Acetylcysteine. Respiration 50: pp. 31-42
- Wagner, PD, Mathieu-Costello, O, Bebout, DE, Gray, AT, Natter-, son PD, Glennow, C (1989) Protection against pulmonary O2tox- icity by N-Acetylcysteine. Eur Respir J 2: pp. 116-126
- Lorber, A, Baumgartner, WA, Bovy, RA, Chang, CC, Hollcraft, R (1973) Ctincal application for heavy metal-complexing potential of N-Acetylcysteine. J Clin Pharmaco1 13: pp. 332-336
- Gofrey, NF, Peter, A, Simon, TM, Lorber, A (1982) IV N-Ace- tylcysteine treatment of hematologic reactions to chrysotherapy. JRheumatol 9: pp. 519-526
- Hjortsr, E, Qvist, J (1988) ARDS after accidental inhalation of zinc chloride smoke. Int Care Med 27: pp. 522-525
- Weidner, MG, Clowes, GHA (1960) The role of the kidney in hy- pocalcemia induced by citrate infusion. Surg Forum 10: pp. 444-449
- Walser, M (1961) Ion association. VII. Dependence of calciuresis on natriuresis during sulfate infusion. Am J Physio1 201: pp. 769-773
- Olsson, B, Johansson, M, Gabrielsson, J, Bolme, P (1988) Pharma- cokinetics and bioavailability of reduced and oxidized N-Ace- tylcysteine. Eur J Clin Pharmaco1 34: pp. 77-82 CrossRef
- Does N-acetylcysteine increase the excretion of trace metals (calcium, magnesium, iron, zinc and copper) when given orally?
European Journal of Clinical Pharmacology
Volume 39, Issue 1 , pp 29-31
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Metal excretion
- Trace metals
- Industry Sectors